MedPath

Extend Biosciences Inc.

Extend Biosciences Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Phase 1 Study of EXT608 in Healthy Adults

Phase 1
Completed
Conditions
Safety Issues
Interventions
Other: Placebo
First Posted Date
2022-06-07
Last Posted Date
2025-02-04
Lead Sponsor
Extend Biosciences Inc.
Target Recruit Count
24
Registration Number
NCT05408663
Locations
🇺🇸

PRA, Lenexa, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath